Potential biomarkers and their regulatory relationships in laryngeal squamous cell carcinoma with lymph node metastasis revealed by integrating mRNA, microRNA and long non-coding RNA profiles

International Journal of Clinical and Experimental Pathology

Volumn 9, Issue 5, 2016, Pages 5103-5116

  Gao, Wei ^a,b   Zhang, Chunming ^a,b   Ma, Teng ^c   Wen, Shuxin ^a,b   Fu, Rong ^b   Zhao, Dan ^b   Wu, Yongyan ^b,d   Wang, Binquan ^a,b  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b Head and Neck Cancer   (China)

^c BEIJING INSTITUTE OF RADIATION MEDICINE   (China)

^d NORTHWEST A F UNIVERSITY   (China)

Author keywords

Cell cycle; Laryngeal squamous cell carcinoma; Long non coding RNA; Lymph node metastasis; MicroRNA; mRNA

Indexed keywords

EID: 84993990091     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Hui AB, Lenarduzzi M, Krushel T, Waldron L, Pintilie M, Shi W, Perez-Ordonez B, Jurisica I, O'Sullivan B, Waldron J, Gullane P, Cummings B, Liu FF. Comprehensive MicroRNA profiling for head and neck squamous cell carcinomas. Clin Cancer Res 2010; 16: 1129-1139.
2. Lian M, Fang J, Han D, Ma H, Feng L, Wang R and Yang F. Microarray gene expression analysis of tumorigenesis and regional lymph node metastasis in laryngeal squamous cell carcinoma. PLoS One 2013; 8: e84854.
3. Wang W, Lin P, Han C, Cai W, Zhao X and Sun B. Research Vasculogenic mimicry contributes to lymph node metastasis of laryngeal squamous cell carcinoma. J Exp Clin Cancer Res 2010; 29: 1-9.
4. Hoffman HT, Porter K, Karnell LH, Cooper JS, Weber RS, Langer CJ, Ang KK, Gay G, Stewart A, Robinson RA. Laryngeal cancer in the United States: changes in demographics, patterns of care, and survival. Laryngoscope 2006; 116: 1-13.
5. Li D, Feng J, Wu T, Wang Y, Sun Y, Ren J and Liu M. Long intergenic noncoding RNA HOTAIR is overexpressed and regulates PTEN methylation in laryngeal squamous cell carcinoma. Am J Pathol 2013; 182: 64-70.
6. Rudolph E, Dyckhoff G, Becher H, Dietz A and Ramroth H. Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis. Eur Arch Otorhinolaryngol 2011; 268: 165-179.
7. Zhang B, Liu W, Li L, Lu J, Liu M, Sun Y and Jin D. KAI1/CD82 and CyclinD1 as biomarkers of invasion, metastasis and prognosis of laryngeal squamous cell carcinoma. Int J Clin Exp Pathol 2013; 6: 1060.
8. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ. Cancer statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
9. Liu WW, Zeng ZY, Wu QL, Hou JH and Chen YY. Overexpression of MMP-2 in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Otolaryngology Head and Neck Surgery 2005; 132: 395-400.
10. Shi Y, Gong HL, Zhou L, Tian J and Wang Y. CD24: a novel cancer biomarker in laryngeal squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec 2011; 74: 78-85.
11. Chen K, Cornejo KM, Ye W, Wu Q, Liang J and Jiang Z. Oncofetal protein IMP3: a new diagnostic biomarker for laryngeal carcinoma. Hum Pathol 2013; 44: 2126-2131.
12. Farazi TA, Hoell JI, Morozov P and Tuschl T. MicroRNAs in human cancer. In: MicroRNA Cancer Regulation Springer; 2013. pp 1-20.
13. Shen Z, Zhan G, Ye D, Ren Y, Cheng L, Wu Z and Guo J. MicroRNA-34a affects the occurrence of laryngeal squamous cell carcinoma by targeting the antiapoptotic gene survivin. Med Oncol 2012; 29: 2473-2480.
14. Li X, Wang Hl, Peng X, Zhou HF and Wang X. miR-1297 mediates PTEN expression and contributes to cell progression in LSCC. Biochem Biophys Res Commun 2012; 427: 254-260.
15. Shen Z, Li Q, Deng H, Lu D, Song H and Guo J. Long Non-Coding RNA Profiling in Laryngeal Squamous Cell Carcinoma and Its Clinical Significance: Potential Biomarkers for LSCC. PLoS One 2014; 9: e108237.
16. Geisler S and Coller J. RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol 2013; 14: 699-712.
17. Feng J, Tian L, Sun Y, Li D, Wu T, Wang Y and Liu M. Expression of long non-coding ribonucleic acid metastasis-associated lung adenocarcinoma transcript-1 is correlated with progress and apoptosis of laryngeal squamous cell carcinoma. Head Neck Oncol 2012; 4: 46.
18. Gautier L, Cope L, Bolstad BM and Irizarry RA. affy-analysis of Affymetrix GeneChip data at the probe level. Bioinformatics 2004; 20: 307-315.
19. Allison DB, Cui X, Page GP and Sabripour M. Microarray data analysis: from disarray to consolidation and consensus. Nat Rev Genet 2006; 7: 55-65.
20. Smyth GK. Limma: linear models for microarray data. In: Bioinformatics and computational biology solutions using R and Bioconductor Springer; 2005. pp. 397-420.
21. Shade A and Handelsman J. Beyond the Venn diagram: the hunt for a core microbiome. Environ Microbiol 2012; 14: 4-12.
22. Consortium GO. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 2004; 32: D258-D261.
23. Kanehisa M, Goto S, Furumichi M, Tanabe M and Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010; 38: D355-D360.
24. Liew AWC, Law NF, Cao XQ and Yan H. Statistical power of Fisher test for the detection of short periodic gene expression profiles. Pattern Recognition 2009; 42: 549-556.
25. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC and Lempicki RA. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003; 4: P3.
26. Wang J. Pearson Correlation Coefficient. In: Encyclopedia of Systems Biology Springer; 2013. pp. 1671-1671.
27. Franchina T, Amodeo V, Bronte G, Savio G, Ricciardi GR, Picciotto M, Russo A, Giordano A and Adamo V. Circulating miR-22, miR-24 and miR-34a as Novel Predictive Biomarkers to Pemetrexed-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer. J Cell Physiol 2014; 229: 97-99.
28. Hua Z, Lv Q, Ye W, Wong CK, Cai G, Gu D, Ji Y, Zhao C, Wang J, Yang BB, Zhang Y. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia. PLoS One 2006; 1: e116.
29. Smoot ME, Ono K, Ruscheinski J, Wang PL and Ideker T. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics 2011; 27: 431-432.
30. Takahashi Y, Sawada G, Kurashige J, Uchi R, Matsumura T, Ueo H, Takano Y, Eguchi H, Sudo T, Sugimachi K, Yamamoto H, Doki Y, Mori M,Mimori K. Amplification of PVT-1 is involved in poor prognosis via apoptosis inhibition in colorectal cancers. Br J Cancer 2014; 110: 164-171.
31. Ding J, Li D, Gong M, Wang J, Huang X, Wu T and Wang C. Expression and clinical significance of the long non-coding RNA PVT1 in human gastric cancer. Onco Targets Ther 2014; 7: 1625.
32. Chen KM, Stephen JK, Havard S, Shah V, Gardner G, Schweitzer VG and Worsham MJ. Novel dysregulated microRNAs in primary laryngeal squamous cell cancer. Cancer 2012 3: 76-81.
33. Chettimada S, Kobelja R, Gupte R and Gupte S. Role Of Glucose-6-Phosphate Dehydrogenase In Pulmonary Artery Smooth Muscle Cell Proliferation & Apoptosis. In: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Am Thoracic Soc, 2011.
34. Alvarez ML, Khosroheidari M, Eddy E and Kiefer J. Role of microRNA 1207-5P and its host gene, the long non-coding RNA Pvt1, as mediators of extracellular matrix accumulation in the kidney: implications for diabetic nephropathy. PLoS One 2013; 8: e77468.
35. Ayaz L, G�r�r A, Yaroglu HY, �zcan C and Tamer L. Differential expression of microRNAs in plasma of patients with laryngeal squamous cell carcinoma: potential early-detection markers for laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol 2013; 139: 1499-1506.
36. Cao P, Zhou L, Zhang J, Zheng F, Wang H, Ma D and Tian J. Comprehensive expression profiling of microRNAs in laryngeal squamous cell carcinoma. Head & Neck 2013; 35: 720-728.
37. Cho WC, Chow AS and Au JS. MiR-145 inhibits cell proliferation of human lung adenocarcinoma by targeting EGFR and NUDT1. RNA Biol 2011; 8: 125-131.
38. Cha HJ, Shin S, Yoo H, Lee EM, Bae S, Yang KH, Lee SJ, Park IC, Jin YW, An S. Identification of ionizing radiation-responsive microRNAs in the IM9 human B lymphoblastic cell line. Int J Oncol 2009; 34: 1661-1668.
39. Yang F and Wang P. The Mammalian synaptonemal complex: a scaffold and beyond. Genome Dyn 2009; 5: 69-80.
40. Yu Q, Sicinska E, Geng Y, Ahnstr�m M, Zagozdzon A, Kong Y, Gardner H, Kiyokawa H, Harris LN, St�l O, Sicinski P. Requirement for CDK4 kinase function in breast cancer. Cancer Cell 2006; 9: 23-32.
41. Pishvaian MJ, Yang S, Zouhairi ME, Wu CS, Mishra L and Avantaggiati ML. Synergistic anti-cancer activity of the CDK4/6 inhibitor PD-0332991 in combination with 5-fluorouracil-based chemotherapy in human colon cancer cells. Cancer Res 2010; 70: 5047.
42. Rivadeneira DB, Mayhew CN, Thangavel C, Sotillo E, Reed CA, Gra�a X and Knudsen ES. Proliferative suppression by CDK4/6 inhibition: complex function of the retinoblastoma pathway in liver tissue and hepatoma cells. Gastroenterology 2010; 138: 1920-1930. e1922.
43. Chen Z, Zeng H, Guo Y, Liu P, Pan H, Deng A and Hu J. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J Exp Clin Cancer Res 2010; 29: 151.
44. Petitjean A, Achatz M, Borresen-Dale A, Hainaut P and Olivier M. TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes. Oncogene 2007; 26: 2157-2165.
45. Ganci F, Sacconi A, Bossel Ben-Moshe N, Manciocco V, Sperduti I, Strigari L, Covello R, Benevolo M, Pescarmona E, Domany E, Muti P, Strano S, Spriano G,Fontemaggi G, Blandino G. Expression of TP53 mutation-associated microRNAs predicts clinical outcome in head and neck squamous cell carcinoma patients. Ann Oncol 2013; 24: 3082-3088.
46. Woo HG, Wang XW, Budhu A, Kim YH, Kwon SM, Tang ZY, Sun Z, Harris CC and Thorgeirsson SS. Association of TP53 mutations with stem cell-like gene expression and survival of patients with hepatocellular carcinoma. Gastroenterology 2011; 140: 1063-1070. e1068.